Phoenix Molecular Designs

Developer of small molecule kinase inhibitors for the treatment of cancer

placeVancouver, British Columbia, Canada calendar_todayFounded 2012 groups12 employees language phoenixmd.ca

Social engagement

Social engagement: 872 social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Pallasite Ventures.

Investor typeCountShare
Venture capital788%
Accelerator & incubator113%

Recent activity

15 May 2026
Product launch
PMD-026
8 Dec 2025
Event
SABCS 2025
7 Jul 2025
Event
2025 Young Women's Health Day on the Hill
Coming soon